Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888674
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer Resectable
Zhejiang University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05557591
What this trial is testing

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT04736810
What this trial is testing

Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 28
Testing effectiveness (Phase 2)UnknownNCT05193188
What this trial is testing

Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Who this might be right for
Chondrosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Testing effectiveness (Phase 2)UnknownNCT03182803
What this trial is testing

CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Research Institute 40
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Not applicableNot Yet RecruitingNCT05660213
What this trial is testing

Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Who this might be right for
Unresectable Hepatocellular Carcinoma
Fudan University 750
Testing effectiveness (Phase 2)Ended earlyNCT03178123
What this trial is testing

The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery

Who this might be right for
Mucosal Melanoma
Shanghai Junshi Bioscience Co., Ltd. 6
Early research (Phase 1)Ended earlyNCT05935098
What this trial is testing

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSolid Tumor
BeiGene 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01313416
What this trial is testing

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsCancer of the PancreasNeoplasms Pancreatic+2 more
Augusta University 2
Testing effectiveness (Phase 2)Ended earlyNCT04688658
What this trial is testing

Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma

Who this might be right for
Unresectable Melanoma
John Kirkwood 13
Testing effectiveness (Phase 2)WithdrawnNCT05690035
What this trial is testing

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancermCRC
Sun Yat-sen University
Testing effectiveness (Phase 2)UnknownNCT05684211
What this trial is testing

Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Celfuture Biotech Co., Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT07674732
What this trial is testing

Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Short-course Radiotherapy Plus ChemotherapyNodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab
Dechang Diao 76
Testing effectiveness (Phase 2)Looking for participantsNCT06978114
What this trial is testing

BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT06957938
What this trial is testing

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

Who this might be right for
Laryngeal CarcinomaHypopharyngeal Carcinoma
Fudan University 168
Testing effectiveness (Phase 2)UnknownNCT05129189
What this trial is testing

Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression

Who this might be right for
HIV Infections
Shanghai Public Health Clinical Center 15
Early research (Phase 1)UnknownNCT03151447
What this trial is testing

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 18
Early research (Phase 1)UnknownNCT04866485
What this trial is testing

Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Who this might be right for
Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd. 66
Next Page